Royal Bank Of Canada Cuts Clarivate (NYSE:CLVT) Price Target to $3.00

Clarivate (NYSE:CLVT) had its price objective cut by research analysts at Royal Bank Of Canada from $5.00 to $3.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price target would indicate a potential upside of 23.71% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. Morgan Stanley reissued an “underweight” rating and issued a $3.00 price target (down from $5.00) on shares of Clarivate in a research report on Wednesday, December 17th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research report on Monday, December 29th. Finally, The Goldman Sachs Group downgraded shares of Clarivate from a “buy” rating to a “neutral” rating and decreased their price target for the company from $4.20 to $3.60 in a research note on Thursday, January 8th. Four research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $3.53.

Clarivate Stock Performance

CLVT traded up $0.08 on Wednesday, hitting $2.43. 2,195,008 shares of the company’s stock were exchanged, compared to its average volume of 7,653,590. Clarivate has a twelve month low of $1.66 and a twelve month high of $4.77. The firm has a market cap of $1.60 billion, a PE ratio of -4.22 and a beta of 1.51. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 0.90. The stock has a fifty day moving average of $2.79 and a two-hundred day moving average of $3.47.

Insider Buying and Selling at Clarivate

In related news, insider Bar Veinstein sold 309,902 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $3.74, for a total value of $1,159,033.48. Following the sale, the insider directly owned 848,811 shares in the company, valued at $3,174,553.14. The trade was a 26.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 23.18% of the company’s stock.

Institutional Investors Weigh In On Clarivate

Institutional investors have recently bought and sold shares of the business. M&T Bank Corp purchased a new position in Clarivate in the fourth quarter valued at about $34,000. Essex Financial Services Inc. bought a new stake in shares of Clarivate in the 3rd quarter valued at approximately $41,000. Jump Financial LLC acquired a new position in Clarivate in the fourth quarter worth approximately $41,000. North Dakota State Investment Board bought a new position in Clarivate during the fourth quarter valued at approximately $42,000. Finally, Beese Fulmer Investment Management Inc. acquired a new stake in Clarivate in the fourth quarter valued at approximately $44,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Key Clarivate News

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Q4 results beat expectations: Q4 EPS $0.20 vs $0.16 est and revenue $617M vs ~$605M consensus; management reiterated momentum and delivered upbeat commentary that helped lift the stock. Clarivate rises over 3% on earnings beat and upbeat guidance
• Positive Sentiment: Management set a target of ~10% free cash flow growth for 2026 and described a strategic portfolio shift — investors view this as evidence of improving cash-generation and sharper focus on higher-return businesses. Clarivate outlines 10 percent free cash flow growth target for 2026 amid strategic portfolio shift
• Positive Sentiment: Company press release highlighted the Value Creation Plan, accelerated ACV growth and higher cash flow; management said FY‑2026 EPS guidance (0.70–0.80) is meaningfully above consensus, supporting near‑term upside. Clarivate Reports Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: Management provided detailed color in the earnings call and slide deck (transcript and presentation available) — useful for investors but no new surprises beyond the published guidance and FCF target. Clarivate Plc (CLVT) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Underlying revenue trends remain a concern: quarterly revenue was down ~6.9% YoY and the company still reports a negative net margin; these fundamentals limit valuation upside until top‑line stabilization is clear. Clarivate quarterly results and metrics (MarketBeat)
• Negative Sentiment: Revenue guidance range ($2.3B–$2.4B) sits at or slightly below consensus midpoint, leaving potential downside risk if demand softness continues despite stronger EPS guidance from cost/cash measures. Clarivate PLC (CLVT) Q4 Earnings and Revenues Beat Estimates (Zacks)

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.